Hyperoxia-induced differential expression of microRNAs mediates lung injury in neonatal rats

doi:10.12307/2023.155

Abstract

Abstract: BACKGROUND: The main pathological features of bronchopulmonary dysplasia are stagnation of lung development and minor tissue damage. Fetal lung development needs to go through five stages, and a preterm infant cannot survive after birth until the cystic stage. Therefore, research on the pathogenesis of premature birth- and hyperoxia-induced bronchopulmonary dysplasia has focused on cystic and alveolar phases.
OBJECTIVE: To investigate the regulatory role of differentially expressed microRNAs in hyperoxia-associated bronchopulmonary dysplasia during two developmental stages – cystic and alveolar stages.
METHODS: Newborn Sprague-Dawley rats were randomly into four groups: in 0 day group (n=10), rat lung tissue was taken immediately after birth; 4-, 7-, 14-day groups were further divided into two subgroups – hyperoxia group (exposed to persistent hyperoxia with an oxygen concentration of 85%-90%, n=10) and air group (exposed to the air with FiO2: 21%, n=10). Lung samples tissue were then taken at postnatal days 4, 7, 14. MicroRNAs in lung tissue were acquired using miRNA-Seq technology to build a library, and sequenced on the Illumina platform. Differently expressed microRNAs between different groups were screened by Deseq2 (Version 1.10.1) and Venn map. Gene ontology enrichment and protein-protein interaction analysis were performed to predict target proteins of differentially expressed microRNAs.
RESULTS AND CONCLUSION: There were 633 microRNAs in the 0-day group, 609, 614, and 584 microRNAs in the hyperoxia group at postnatal days 4, 7, 14, respectively, and 629, 608, and 581 in the corresponding air groups. The hyperoxia group obtained 130, 3, and 114 differentially expressed microRNAs during postnatal days 0-4 (cystic stage), 4-7, and 4-14 (alveolar stage), respectively. And the corresponding air group received 106, 0, 111 differentially expressed microRNAs respectively. There were 91, 0, and 79 differentially expressed microRNAs in the two groups at different stages. During the cystic and alveolar phases, miR-34a-5p and miR-21-5p were significantly expressed in the lung tissue of neonatal rats in the hyperoxia group. miR-34a-5p had 198 target proteins, which concentrated around the Pdgfrb/Pdgfra/Ngfr; miR-21-5p had 302 target proteins that mainly revolved around the Mapk1/Stat3. To conclude, miR-34a-5p and miR-21-5p are highly expressed in the cystic and alveolar stages under hyperoxia exposure, targeting the proteins about PDGFRB/PDGFRA/NGFR and MAPK1/Stat3 respectively, which mediate the process of lung development and participate in the occurrence and development of bronchopulmonary dysplasia.

Key words: bronchopulmonary dysplasia, microRNA high-throughput sequencing, miRNA-21-5p, miR-34a-5p, MAPK1/Start3, PDGFRB/PDGFRA/NGFR

CLC Number:

Wang Lina, Zhang Rong, Kang Lan, Lei Xiaoping, He Hongxia, Dong Wenbin. Hyperoxia-induced differential expression of microRNAs mediates lung injury in neonatal rats[J]. Chinese Journal of Tissue Engineering Research, 2023, 27(11): 1692-1700.

Figures/Tables 9

References

[1] NORTHWAY WH JR, ROSAN RC, PORTER DY. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276:357-368.
[2] HIGGINS RD, JOBE AH, KOSO-THOMAS M, et al. Bronchopulmonary Dysplasia: Executive Summary of a Workshop.J Pediatr. 2018;197:300-308.
[3] BONADIES L, ZARAMELLA P, PORZIONATO A, et al. Present and Future of Bronchopulmonary Dysplasia. J Clin Med. 2020;9(5):1539.
[4] KALIKKOT THEKKEVEEDU R, GUAMAN MC, SHIVANNA B. Bronchopulmonary dysplasia: A review of pathogenesis and pathophysiology. Respir Med. 2017;132: 170-177.
[5] DAY CL, RYAN RM. Bronchopulmonary dysplasia: new becomes old again! Pediatr Res. 2017;81:210-213.
[6] IBRAHIM J, BHANDARI V. The definition of bronchopulmonary dysplasia: an evolving dilemma. Pediatr Res. 2018;84:586-588.
[7] JAIN D, FELDMAN A, SANGAM S. Predicting Long-Term Respiratory Outcomes in Premature Infants: Is It Time to Move beyond Bronchopulmonary Dysplasia? Children (Basel). 2020;7(12):283.
[8] JOBE AJ. The new BPD: an arrest of lung development. Pediatr Res. 1999; 46:641-643.
[9] BAUD O, WATTERBERG KL. Prophylactic postnatal corticosteroids: Early hydrocortisone. Semin Fetal Neonatal Med. 2019;24:202-206.
[10] HOU Y, LIU M, HUSTED C, et al. Activation of the nuclear factor-kappaB pathway during postnatal lung inflammation preserves alveolarization by suppressing macrophage inflammatory protein-2. Am J Physiol Lung Cell Mol Physiol. 2015;309:L593-604.
[11] MOHAMED I, ELREMALY W, ROULEAU T, et al. Oxygen and parenteral nutrition two main oxidants for extremely preterm infants: ‘It all adds up’. J Neonatal Perinatal Med. 2015;8:189-197.
[12] WARNER BB, STUART LA, PAPES RA, et al. Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol. 1998;275:L110-117.
[13] ABDEL GHANY EA, ALSHARANY W, ALI AA, et al. Anti-oxidant profiles and markers of oxidative stress in preterm neonates. Paediatr Int Child Health. 2016;36(2):134-140.
[14] TANG J, DIAO P, SHU X, et al. Quercetin and Quercitrin Attenuates the Inflammatory Response and Oxidative Stress in LPS-Induced RAW264.7 Cells: In Vitro Assessment and a Theoretical Model. Biomed Res Int. 2019; 2019:7039802.
[15] ZHANG XF, FODA HD. [Pulmonary apoptosis and necrosis in hyperoxia-induced acute mouse lung injury]. Zhonghua Jie He He Hu Xi Za Zhi. 2004; 27:465-468.
[16] NARASARAJU TA, CHEN H, WENG T, et al. Expression profile of IGF system during lung injury and recovery in rats exposed to hyperoxia: a possible role of IGF-1 in alveolar epithelial cell proliferation and differentiation. J Cell Biochem. 2006;97:984-998.
[17] DU T, ZAMORE PD. microPrimer: the biogenesis and function of microRNA. Development. 2005;132:4645-4652.
[18] SAHNI M, BHANDARI V. Recent advances in understanding and management of bronchopulmonary dysplasia. F1000Res. 2020;9:F1000 Faculty Rev-703. doi: 10.12688/f1000research.25338.1. eCollection 2020.
[19] AMEIS D, KHOSHGOO N, IWASIOW BM, et al. MicroRNAs in Lung Development and Disease. Paediatr Respir Rev. 2017;22:38-43.
[20] LAL CV, OLAVE N, TRAVERS C, et al. Exosomal microRNA predicts and protects against severe bronchopulmonary dysplasia in extremely premature infants. JCI Insight. 2018;3(5):e93994.
[21] SCHITTNY JC. Development of the lung. Cell Tissue Res. 2017;367:427-444.
[22] DONG J, JIANG G, ASMANN YW, et al. MicroRNA networks in mouse lung organogenesis. PLoS One. 2010;5:e10854.
[23] LIGNELLI E, PALUMBO F, MYTI D, et al. Recent advances in our understanding of the mechanisms of lung alveolarization and bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2019;317:L832-l887.
[24] AMBALAVANAN N, COTTEN CM, PAGE GP, et al. Integrated genomic analyses in bronchopulmonary dysplasia. J Pediatr. 2015;166:531-537 e513.
[25] ZHU X, LEI X, WANG J, et al. Protective effects of resveratrol on hyperoxia-induced lung injury in neonatal rats by alleviating apoptosis and ROS production. J Matern Fetal Neonatal Med. 2020;33:4150-4158.
[26] SURATE SOLALIGUE DE, RODRÍGUEZ-CASTILLO JA, AHLBRECHT K, et al. Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2017;313(6):L1101-L1153.
[27] BURRI PH. Structural aspects of postnatal lung development - alveolar formation and growth. Biol Neonate. 2006;89:313-322.
[28] POPOVA AP, BENTLEY JK, CUI TX, et al. Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2014;307:L231-239.
[29] COHEN ED, IHIDA-STANSBURY K, LU MM, et al. Wnt signaling regulates smooth muscle precursor development in the mouse lung via a tenascin C/PDGFR pathway. J Clin Invest. 2009;119:2538-2549.
[30] RHEE CK, LEE SH, YOON H, et al. Effect of nilotinib on bleomycin-induced acute lung injury and pulmonary fibrosis in mice. Respiration. 2011;82:273-287.
[31] GORTNER L, SHEN J, TUTDIBI E. Sexual dimorphism of neonatal lung development. Klin Padiatr. 2013;225 64-69.
[32] RUIZ-CAMP J, QUANTIUS J, LIGNELLI E, et al. Targeting miR-34a/Pdgfra interactions partially corrects alveologenesis in experimental bronchopulmonary dysplasia. Embo Mol Med. 2019;11:17.
[33] SYED M, DAS P, PAWAR A, et al. Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs. Nat Commun. 2017;8:1173.
[34] SULTAN M, ALGHETAA H, MOHAMMED A, et al. The Endocannabinoid Anandamide Attenuates Acute Respiratory Distress Syndrome by Downregulating miRNA that Target Inflammatory Pathways. Front Pharmacol. 2021;12:644281.
[35] ALHARRIS E, ALGHETAA H, SETH R, et al. Resveratrol Attenuates Allergic Asthma and Associated Inflammation in the Lungs Through Regulation of miRNA-34a That Targets FoxP3 in Mice. Front Immunol. 2018;9:2992.
[36] SACHINIDIS A, LOCHER R, VETTER W, et al. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J Biol Chem. 1990;265:10238-10243.
[37] ANDRAE J, GALLINI R, BETSHOLTZ C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22:1276-1312.
[38] HE C, MEDLEY SC, KIM J, et al. STAT1 modulates tissue wasting or overgrowth downstream from PDGFRbeta. Genes Dev. 2017;31:1666-1678.
[39] LI J, MA J, LI M, et al. GYY4137 alleviates sepsis-induced acute lung injury in mice by inhibiting the PDGFRβ/Akt/NF-κB/NLRP3 pathway. Life Sci. 2021; 271:119192.
[40] PARSI S, SOLTANI BM, HOSSEINI E, et al. Experimental verification of a predicted intronic microRNA in human NGFR gene with a potential pro-apoptotic function. PLoS One. 2012;7:e35561.
[41] CHANG L, KARIN M. Mammalian MAP kinase signalling cascades. Nature. 2001;410:37-40.
[42] CARGNELLO M, ROUX PP. Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases. Microbiol Mol Biol Rev. 2011;75(1):50-83.
[43] HAMVAS A, FENG R, BI Y, et al. Exome sequencing identifies gene variants and networks associated with extreme respiratory outcomes following preterm birth. BMC Genet. 2018;19:94.
[44] LI J, LI Y, HE H, et al. Csk/Src/EGFR signaling regulates migration of myofibroblasts and alveolarization. Am J Physiol Lung Cell Mol Physiol. 2016; 310:L562-571.
[45] DAMMANN CE, NIELSEN HC, CARRAWAY KL, 3RD. Role of neuregulin-1 beta in the developing lung. Am J Respir Crit Care Med. 2003;167:1711-1716.
[46] PUREVDORJ E, ZSCHEPPANG K, HOYMANN HG, et al. ErbB4 deletion leads to changes in lung function and structure similar to bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2008;294:L516-522.
[47] LIN CK, LIN YH, HUANG TC, et al. VEGF mediates fat embolism-induced acute lung injury via VEGF receptor 2 and the MAPK cascade. Sci Rep. 2019; 9:11713.
[48] REINHARDT J, LANDSBERG J, SCHMID-BURGK JL, et al. MAPK Signaling and Inflammation Link Melanoma Phenotype Switching to Induction of CD73 during Immunotherapy. Cancer Res. 2017;77:4697-4709.
[49] MO W, LI Y, CHANG W, et al. The Role of LncRNA H19 in MAPK Signaling Pathway Implicated in the Progression of Bronchopulmonary Dysplasia. Cell Transplant. 2020;29:963689720918294.
[50] ZHAO W, MA L, CAI C, et al. Caffeine Inhibits NLRP3 Inflammasome Activation by Suppressing MAPK/NF-κB and A2aR Signaling in LPS-Induced THP-1 Macrophages. Int J Biol Sci. 2019;15:1571-1581.
[51] KANODIA J, CHAI D, VOLLMER J, et al. Deciphering the mechanism behind Fibroblast Growth Factor (FGF) induced biphasic signal-response profiles. Cell Commun Signal. 2014;12:34.
[52] SHRESTHA AK, MENON RT, YALLAMPALLI C, et al. Adrenomedullin Deficiency Potentiates Lipopolysaccharide-Induced Experimental Bronchopulmonary Dysplasia in Neonatal Mice. Am J Pathol. 2021;191(12):2080-2090.
[53] ZHANG ZQ, HONG H, LI J, et al. MicroRNA-214 promotes alveolarization in neonatal rat models of bronchopulmonary dysplasia via the PlGF-dependent STAT3 pathway. Mol Med. 2021;27:109.
[54] ZHAO YR, WANG D, LIU Y, et al. The PI3K/Akt, p38MAPK, and JAK2/STAT3 signaling pathways mediate the protection of SO2 against acute lung injury induced by limb ischemia/reperfusion in rats. J Physiol Sci. 2016;66:229-239.
[55] FRUMAN DA, CHIU H, HOPKINS BD, et al. The PI3K Pathway in Human Disease. Cell. 2017;170:605-635.
[56] ZHANG L, WANG P, SHEN Y, et al. Mechanism of lncRNA H19 in Regulating Pulmonary Injury in Hyperoxia-Induced Bronchopulmonary Dysplasia Newborn Mice. Am J Perinatol. 2020. doi: 10.1055/s-0040-1721498.
[57] MENG A, ZHANG X, SHI Y. Role of p38 MAPK and STAT3 in lipopolysaccharide-stimulated mouse alveolar macrophages. Exp Ther Med. 2014;8:1772-1776.
[58] NI Y, WU S, WANG X, et al. Cucurbitacin I induces pro-death autophagy in A549 cells via the ERK-mTOR-STAT3 signaling pathway. J Cell Biochem. 2018; 119:6104-6112.
[59] LIU X, CHEN M, CHEN B, et al. Advance in research of microRNA-21-5p regulate autophagy by targeting gene. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020;32:112-117.
[60] QIN S, CHEN M, JI H, et al. miR-21-5p regulates type II alveolar epithelial cell apoptosis in hyperoxic acute lung injury. Mol Med Rep. 2018;17:5796-5804.
[61] ZHANG W, XU L, CHEN M, et al. Effect of overexpression of microRNA-21-5p on early apoptosis of type II alveolar epithelial cells in rats with hyperoxic acute lung injury. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019;31:978-982.
[62] QI A, WANG T, LI W, et al. The effect of miR-21-5p on the MAP2K3 expressions and cellular apoptosis in the lung tissues of neonatal rats with hyperoxia-induced lung injuries. Am J Transl Res. 2021;13:2784-2793.